BIO-IMPLANT MARKET ANALYSIS

Bio-implant Market, By Product Type (Cardiovascular Implants, Dental Implants, Spinal Bio-implants, Orthopedic Implants, Ophthalmic Implants, and Others), By Material Type (Biomaterial Metal, Ceramic, Alloys, and Polymer), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI3050
Pages :178
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Global Bio-implant Market- Key Trends

Increasing Number of Product Approvals By Regulatory Bodies

Key market players are focused on organic growth strategies such as gaining product approvals from regulatory bodies, and this is expected to drive the bio-implant market growth over the forecast period. For instance, in August 2021, Zimmer Biomet Holdings, Inc., a global medical technology leader, and Canary Medical, a medical data company, announced that the U.S. Food and Drug Administration (FDA) has provided De Novo classification grant and authorization to market the tibial extension for Persona IQ, the world's first and only smart knee cleared by the U.S. FDA for total knee replacement surgery. Persona IQ combines Zimmer Biomet's proven and trusted knee implantnamed Persona The Personalized Knee with Canary Medical's proprietary implantable canturioTMte tibial extension sensor technology that measures and determines range of motion, step count, walking speed, and other gait metrics. Persona IQ will work together with Zimmer Biomet's remote care management platform, mymobility with Apple Watch, as well as other components of the ZBEdge Connected Intelligence Suite.